Senate approves pharmacy access to contraceptives after heated fight over corn-masa folic‑acid mandate

The Georgia Senate on its final day passed House Bill 1138, a measure that allows pharmacists to dispense certain self‑administered hormonal contraceptives and to administer injectable contraceptives under a state protocol, and requires insurers to cover defined supplies. Sponsors said the bill will expand access in counties with few obstetrician‑gynecologists and reduce barriers to preventive care.

Senator Watson, who carried the bill for the Senate Committee on Health and Human Services, said pharmacists would only provide contraception under a formal protocol between the state health department and the Georgia Composite Medical Board, would complete a training certificate, and would be required to check for medical contraindications and refer patients to a physician when appropriate. “No pharmacist is required to participate,” Watson said in floor remarks, adding the bill allows an initial three‑month supply and up to 12 months for renewals.

The measure’s floor consideration became politically charged after the Health Committee added an unrelated public‑health provision that would have required folic‑acid fortification of corn‑masa flour — a change supporters said would cut neural‑tube birth defects that disproportionately affect some communities. A senator who championed the corn‑masa amendment described the fortification proposal as “one of the top public‑health triumphs of the 20th century” and urged colleagues not to strip the provision from the bill.

Opponents of attaching the food‑fortification language said it risked jeopardizing the contraception measure’s passage and could prompt a veto because it had not been vetted or funded in the same process as the main bill. After extended debate, the Senate adopted an amendment to remove the corn‑masa requirement from HB 1138; the contraceptive portion was retained and passed by the constitutional majority required for a House bill.

Supporters portrayed the final bill as a pragmatic expansion of access — particularly in rural counties with limited women’s health care — that preserves physicians’ role while allowing trained pharmacists to provide time‑sensitive prevention. Opponents argued the legislature should not add unrelated mandates to an access bill. The Senate reported the passage of HB 1138 by substitute and sent the bill on to the next step in the process.

The next procedural step for implementation will be rulemaking by the Department of Public Health and the medical and pharmacy licensing boards to establish the joint protocol and the required pharmacist training. The Senate recorded the passage of the bill on the final day of the session.